A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials

Abstract Background Safe, more efficacious treatments are needed to address the considerable morbidity and mortality associated with pulmonary tuberculosis (TB). However, the current practice in TB therapeutics trials is to use composite binary outcomes, which in the absence of standardization may i...

Full description

Bibliographic Details
Published in:Trials
Main Authors: N. K. Hills, J. Lyimo, P. Nahid, R. M. Savic, C. Lienhardt, P. P. J. Phillips
Format: Article
Language:English
Published: BMC 2021-08-01
Online Access:https://doi.org/10.1186/s13063-021-05388-1